AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11014375 — intervention group
Group type: COMPARATOR
Intervention: Vasodilator therapy in mitral valve prolapse or hypertrophic cardiomyopathy
Number of subjects: 0
Study 11014375 — intervention group
Group type: COMPARATOR
Intervention: Vasodilator therapy in other primary causes of MR
Number of subjects: 0
Study 8617901 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt-sensitive hypertensive patients
Number of subjects: 65
Study 8617901 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt-sensitive hypertensive patients < 44 years
Number of subjects: 65
Study 8617901 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt-sensitive hypertensive patients 44 to 64 years
Number of subjects: 65
Study 8617901 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt-sensitive hypertensive patients > or = 65 years
Number of subjects: 65
Study 8617901 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt-sensitive hypertensive patients of all ages
Number of subjects: 65
Study 8617901 — intervention group
Group type: COMPARATOR
Intervention: Normotensive controls
Number of subjects: 65
Study 1359210 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 70
Study 1359210 — intervention group
Group type: COMPARATOR
Intervention: Mini cholecystectomy (MC)
Number of subjects: 70
Study 6545088 — intervention group
Group type: EXPERIMENTAL
Intervention: Valium Roche mixed Micelles
Number of subjects: 119
Study 6545088 — intervention group
Group type: COMPARATOR
Intervention: Diazemuls
Number of subjects: 119
Study 30702758 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted guided internet‐based cognitive behavior therapy (ICBT) for 8 weeks
Number of subjects: 50
Study 30702758 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 50
Study 30446003 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening trial prior to SCS implant
Number of subjects: 100
Study 30446003 — intervention group
Group type: COMPARATOR
Intervention: Implantation-only strategy
Number of subjects: 100
Study 26415549 — intervention group
Group type: EXPERIMENTAL
Intervention: Temoporfin photodynamic therapy (PDT) plus chemotherapy and stent
Number of subjects: 20
Study 26415549 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy and stent without temoporfin PDT
Number of subjects: 20
Study 25515570 — intervention group
Group type: COMPARATOR
Intervention: Normal eyes (control group)
Number of subjects: 22
Study 25515570 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyes with retinitis pigmentosa (RP)
Number of subjects: 22
Study 25515570 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (normal and RP)
Number of subjects: 22
Study 22101166 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA methylation at GNASAS
Number of subjects: 122
Study 22101166 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA methylation at INS
Number of subjects: 122
Study 22101166 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypermethylation at one locus
Number of subjects: 122
Study 22101166 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypermethylation at both loci
Number of subjects: 122
Study 22101166 — intervention group
Group type: COMPARATOR
Intervention: No association
Number of subjects: 122
Study 19396540 — intervention group
Group type: EXPERIMENTAL
Intervention: RSA biofeedback
Number of subjects: 38
Study 19396540 — intervention group
Group type: COMPARATOR
Intervention: Progressive muscle relaxation (PMR)
Number of subjects: 38
Study 17897821 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin
Number of subjects: 776
Study 17897821 — intervention group
Group type: COMPARATOR
Intervention: Control (no further treatment)
Number of subjects: 776
Study 15295370 — intervention group
Group type: COMPARATOR
Intervention: Foley catheter alone (Foley)
Number of subjects: 100
Study 15295370 — intervention group
Group type: EXPERIMENTAL
Intervention: Foley catheter with extra-amniotic saline infusion (EASI)
Number of subjects: 100
Study 11578668 — intervention group
Group type: EXPERIMENTAL
Intervention: Major Depression Inventory (MDI)
Number of subjects: 43
Study 11578668 — intervention group
Group type: EXPERIMENTAL
Intervention: MDI total score
Number of subjects: 43
Study 9660036 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice
Number of subjects: 22
Study 9660036 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange juice
Number of subjects: 22
Study 9660036 — intervention group
Group type: COMPARATOR
Intervention: Mineral water
Number of subjects: 22
Study 7988297 — intervention group
Group type: COMPARATOR
Intervention: S measurements (in-shoe foot pressure)
Number of subjects: 109
Study 7988297 — intervention group
Group type: COMPARATOR
Intervention: H measurements (foot pressure between foot and sock)
Number of subjects: 109
Study 7988297 — intervention group
Group type: COMPARATOR
Intervention: B measurements (foot pressure with socks only)
Number of subjects: 109
Study 7988297 — intervention group
Group type: COMPARATOR
Intervention: Peak S pressure
Number of subjects: 109
Study 7988297 — intervention group
Group type: COMPARATOR
Intervention: Peak H pressure
Number of subjects: 109
Study 7988297 — intervention group
Group type: COMPARATOR
Intervention: Peak B pressure
Number of subjects: 109
Study 3141296 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose
Number of subjects: 24
Study 3141296 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose
Number of subjects: 24
Study 3141296 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol
Number of subjects: 24
Study 3141296 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 24
Study 29930229 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR) therapy
Number of subjects: 100
Study 29930229 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study 27017108 — intervention group
Group type: EXPERIMENTAL
Intervention: Water Exchange (WE)
Number of subjects: 704
Study 27017108 — intervention group
Group type: COMPARATOR
Intervention: Sedation
Number of subjects: 704
Study 24978090 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured training program
Number of subjects: 165
Study 24978090 — intervention group
Group type: COMPARATOR
Intervention: Unstructured training program
Number of subjects: 165
Study 22263648 — intervention group
Group type: EXPERIMENTAL
Intervention: Inversion + physiotherapy
Number of subjects: 24
Study 22263648 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy alone (control)
Number of subjects: 24
Study 20959284 — intervention group
Group type: EXPERIMENTAL
Intervention: Titrated oxygen treatment
Number of subjects: 405
Study 20959284 — intervention group
Group type: COMPARATOR
Intervention: High flow oxygen treatment
Number of subjects: 405
Study 18238963 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal contraceptive (0.75 mg ethinyl estradiol and 6 mg norelgestromin)
Number of subjects: 24
Study 18238963 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive (35 mcg ethinyl estradiol and 250 mcg norgestimate)
Number of subjects: 24
Study 18238963 — intervention group
Group type: COMPARATOR
Intervention: Transdermal contraceptive
Number of subjects: 24
Study 16792583 — intervention group
Group type: EXPERIMENTAL
Intervention: drugs + SLIT
Number of subjects: 68
Study 16792583 — intervention group
Group type: COMPARATOR
Intervention: drugs + placebo
Number of subjects: 68
Study 14624409 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha-blockade (prazosin 3 mg/d)
Number of subjects: 16
Study 14624409 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study 11053072 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg twice daily orally for three months
Number of subjects: 18
Study 11053072 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 11053072 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 18
Study 8932352 — intervention group
Group type: EXPERIMENTAL
Intervention: Early alternating chemotherapy
Number of subjects: 124
Study 8932352 — intervention group
Group type: COMPARATOR
Intervention: Late alternating chemotherapy
Number of subjects: 124
Study 1434266 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant combination chemotherapy including cis‐platinum
Number of subjects: 50
Study 1434266 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant combination chemotherapy including cis‐platinum with 3 or more cycles
Number of subjects: 50
Study 1434266 — intervention group
Group type: EXPERIMENTAL
Intervention: Histologic grade 2 anaplasia
Number of subjects: 50
Study 1434266 — intervention group
Group type: COMPARATOR
Intervention: OK‐432 or TJ‐48
Number of subjects: 50
Study 1434266 — intervention group
Group type: COMPARATOR
Intervention: Pre‐operative treatment such as irradiation and intra‐arterial chemotherapy
Number of subjects: 50
Study 1434266 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (general)
Number of subjects: 50
Study 3904322 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol-hydralazine treatment
Number of subjects: 161
Study 3904322 — intervention group
Group type: COMPARATOR
Intervention: Non-pharmacological management (Control)
Number of subjects: 161
Study 30808196 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial intervention including five low-moderate intensity 4 km nurse-guided walks, a smartphone application, and a diet workshop
Number of subjects: 204
Study 30808196 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial intervention
Number of subjects: 204
Study 30808196 — intervention group
Group type: COMPARATOR
Intervention: Control group (counselled on physical activity and healthy diet)
Number of subjects: 204
Study 29277158 — intervention group
Group type: EXPERIMENTAL
Intervention: Symbiotic treatment (Lactobacillus paracasei, L. rhamnosus, L. acidophilus, Bifidobacterium lactis plus 6 g of fructo‐oligosaccharides)
Number of subjects: 36
Study 29277158 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo: 6 g of maltodextrin)
Number of subjects: 36
Study 29277158 — intervention group
Group type: EXPERIMENTAL
Intervention: Symbiotic treatment
Number of subjects: 36
Study 29277158 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study 26038091 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg intravenous rontalizumab every 4 weeks
Number of subjects: 238
Study 26038091 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg subcutaneous rontalizumab every 2 weeks
Number of subjects: 238
Study 26038091 — intervention group
Group type: EXPERIMENTAL
Intervention: rontalizumab in ISM-Low patients
Number of subjects: 238
Study 26038091 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 238
Study 24190613 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg sildenafil per day for 12 weeks
Number of subjects: 39
Study 24190613 — intervention group
Group type: COMPARATOR
Intervention: 400 IU vitamin E per day
Number of subjects: 39
Study 22894176 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Acupuncture Group (TAG)
Number of subjects: 30
Study 22894176 — intervention group
Group type: COMPARATOR
Intervention: Control Acupuncture Group (CAG)
Number of subjects: 30
Study 22894176 — intervention group
Group type: EXPERIMENTAL
Intervention: Migraine Group (MG)
Number of subjects: 30
Study 20571436 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra methadone (50% extra dose on top of prescribed daily dosage)
Number of subjects: 28
Study 20571436 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 18607304 — intervention group
Group type: EXPERIMENTAL
Intervention: Training on nasal model (NM) for 15 minutes
Number of subjects: 20
Study 18607304 — intervention group
Group type: COMPARATOR
Intervention: No training on nasal model (NM)
Number of subjects: 20
Study 16380486 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid infusion (LIP) with plasma FFA approximately 1,034 micromol/l
Number of subjects: 0
Study 16380486 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid infusion (LIP)
Number of subjects: 0
Study 16380486 — intervention group
Group type: COMPARATOR
Intervention: Control (CON) without lipid infusion
Number of subjects: 0
Study 16380486 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 0
Study 12760698 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyract Flow (Dentsply DeTrey) with acid etching and/or bonding agent
Number of subjects: 60
Study 12760698 — intervention group
Group type: COMPARATOR
Intervention: Delton FS+ (Dentsply International)
Number of subjects: 60
Study 12760698 — intervention group
Group type: EXPERIMENTAL
Intervention: Air abrasion alone
Number of subjects: 60
Study 10790815 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% tretinoin cream (Retinova)
Number of subjects: 0
Study 10790815 — intervention group
Group type: COMPARATOR
Intervention: Excipient
Number of subjects: 0
Study 8824695 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.375 mg
Number of subjects: 16
Study 8824695 — intervention group
Group type: COMPARATOR
Intervention: Triazolam
Number of subjects: 16
Study 1429786 — intervention group
Group type: EXPERIMENTAL
Intervention: Marshall‐MacIntosh technique with Kennedy ligament‐augmentation device
Number of subjects: 64
Study 1429786 — intervention group
Group type: COMPARATOR
Intervention: Marshall‐MacIntosh technique alone (Control)
Number of subjects: 64
Study 3841005 — intervention group
Group type: EXPERIMENTAL
Intervention: BRL 20627 (10 mg i.v.)
Number of subjects: 0
Study 3841005 — intervention group
Group type: EXPERIMENTAL
Intervention: Zetidoline (20 mg orally)
Number of subjects: 0
Study 3841005 — intervention group
Group type: EXPERIMENTAL
Intervention: BK 34/530 (50 mg orally)
Number of subjects: 0
Study 3841005 — intervention group
Group type: EXPERIMENTAL
Intervention: BK 34/530 (100 mg orally)
Number of subjects: 0
Study 3841005 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3841005 — intervention group
Group type: EXPERIMENTAL
Intervention: All three drugs
Number of subjects: 0
Study 30585498 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused extracorporeal shock wave therapy (f‐ESWT)
Number of subjects: 50
Study 30585498 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound therapy (UST)
Number of subjects: 50
Study 30585498 — intervention group
Group type: EXPERIMENTAL
Intervention: Both f‐ESWT and UST
Number of subjects: 50
Study 28315812 — intervention group
Group type: EXPERIMENTAL
Intervention: VTE patients
Number of subjects: 83
Study 25790903 — intervention group
Group type: EXPERIMENTAL
Intervention: UPSA-M
Number of subjects: 34
Study 25790903 — intervention group
Group type: EXPERIMENTAL
Intervention: UPSA-M Brief
Number of subjects: 34
Study 25790903 — intervention group
Group type: COMPARATOR
Intervention: Traditional UPSA scores, UPSA-B scores, and neuropsychological performance
Number of subjects: 34
Study 25790903 — intervention group
Group type: COMPARATOR
Intervention: Symptoms of psychopathology, experience with tablet technology, or difficulties operating the device
Number of subjects: 34
Study 24325052 — intervention group
Group type: EXPERIMENTAL
Intervention: Thread-moxa in Zhuang folk medicine combined with acupuncture and Jingwanhong Scald Ointment
Number of subjects: 60
Study 24325052 — intervention group
Group type: COMPARATOR
Intervention: Famciclovir Tablet, nimesulide dispersible tablet, vitamin B1, ribavirin ointment (Control)
Number of subjects: 60
Study 21506242 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 91
Study 21506242 — intervention group
Group type: COMPARATOR
Intervention: treatment as usual (TAU)
Number of subjects: 91
Study 17487211 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant sterol-enriched margarine (2.5 g/day)
Number of subjects: 41
Study 17487211 — intervention group
Group type: EXPERIMENTAL
Intervention: Stanol-enriched margarine (2.5 g/day)
Number of subjects: 41
Study 17487211 — intervention group
Group type: COMPARATOR
Intervention: Control margarine (no added plant sterols or stanols)
Number of subjects: 41
Study 17241586 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional injections of bleomycin with electroporation (EP)
Number of subjects: 12
Study 17241586 — intervention group
Group type: COMPARATOR
Intervention: Intralesional injections of bleomycin alone
Number of subjects: 12
Study 15229960 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen sodium 660 mg
Number of subjects: 444
Study 15229960 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen sodium 440 mg
Number of subjects: 444
Study 15229960 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 1200 mg
Number of subjects: 444
Study 15229960 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen sodium 440 mg (subgroup aged > or = 65 years)
Number of subjects: 444
Study 15229960 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 1200 mg (subgroup aged > or = 65 years)
Number of subjects: 444
Study 15229960 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen sodium 440/660 mg
Number of subjects: 444
Study 15229960 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 444
Study 11194534 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent gastric bolus (IGB)
Number of subjects: 28
Study 11194534 — intervention group
Group type: COMPARATOR
Intervention: Continuous gastric infusion (CGI)
Number of subjects: 28
Study 9113631 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary Arachidonic Acid (1.7 g/d for 50 days)
Number of subjects: 10
Study 9113631 — intervention group
Group type: COMPARATOR
Intervention: Control Diet (210 mg/d of Arachidonic Acid)
Number of subjects: 10
Study 8471596 — intervention group
Group type: EXPERIMENTAL
Intervention: Adoptive chemoimmunotherapy (ACIT) using autolymphocyte therapy (ALT) and cyclophosphamide
Number of subjects: 21
Study 3980432 — intervention group
Group type: EXPERIMENTAL
Intervention: Equivalence training
Number of subjects: 0
Study 3980432 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional object-use
Number of subjects: 0
Study 3980432 — intervention group
Group type: COMPARATOR
Intervention: Repeated practice trials
Number of subjects: 0
Study 30921345 — intervention group
Group type: EXPERIMENTAL
Intervention: Picosulfate/magnesium citrate (PMC)
Number of subjects: 171
Study 30921345 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene glycol (PEG)
Number of subjects: 171
Study 30921345 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-day split dose regimen
Number of subjects: 171
Study 30921345 — intervention group
Group type: COMPARATOR
Intervention: One-day split dose regimen
Number of subjects: 171
Study 29178519 — intervention group
Group type: EXPERIMENTAL
Intervention: Semaglutide
Number of subjects: 0
Study 29178519 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26938163 — intervention group
Group type: EXPERIMENTAL
Intervention: Tap water cleansing
Number of subjects: 22
Study 26938163 — intervention group
Group type: COMPARATOR
Intervention: Sterile normal saline cleansing
Number of subjects: 22
Study 24011465 — intervention group
Group type: EXPERIMENTAL
Intervention: PBO (n = 18)
Number of subjects: 40
Study 24011465 — intervention group
Group type: COMPARATOR
Intervention: Grinding method (n = 22)
Number of subjects: 40
Study 24011465 — intervention group
Group type: EXPERIMENTAL
Intervention: PBO segments with fixation
Number of subjects: 40
Study 24011465 — intervention group
Group type: EXPERIMENTAL
Intervention: PBO segments without fixation
Number of subjects: 40
Study 22473943 — intervention group
Group type: EXPERIMENTAL
Intervention: Health intervention RCT
Number of subjects: 527
Study 22473943 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline assessments
Number of subjects: 527
Study 19840783 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 20mg
Number of subjects: 35
Study 17684801 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatine treatment for 21 days
Number of subjects: 21
Study 17684801 — intervention group
Group type: COMPARATOR
Intervention: Control group (basis therapy only)
Number of subjects: 21
Study 15614200 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucomannan (Chrombalance)
Number of subjects: 176
Study 15614200 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucomannan and guar gum (Appe-Trim)
Number of subjects: 176
Study 15614200 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucomannan, guar gum and alginate (Glucosahl)
Number of subjects: 176
Study 15614200 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study 12166585 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 483
Study 12166585 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 483
Study 10204900 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg morphine diluted in 100 mL 0.9% normal saline (NS) and placebo intramuscular (i.m.) (peripheral MS group)
Number of subjects: 45
Study 10204900 — intervention group
Group type: COMPARATOR
Intervention: 100 mL of 0.9% NS alone and placebo i.m. (placebo group)
Number of subjects: 45
Study 10204900 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mL of 0.9% NS and 6 mg morphine i.m. in the deltoid muscle (i.m. MS group)
Number of subjects: 45
Study 8657439 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional intravenous guanethidine blockade (RGB)
Number of subjects: 13
Study 8657439 — intervention group
Group type: COMPARATOR
Intervention: Placebo (tourniquet inflation and i.v. injection of saline)
Number of subjects: 13
Study 2187006 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium dobesilate (1000 mg twice daily)
Number of subjects: 41
Study 2187006 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 382151 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone (10 mg orally t.d.s. before meals)
Number of subjects: 40
Study 382151 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31913228 — intervention group
Group type: EXPERIMENTAL
Intervention: TX-001HR (17β-estradiol/progesterone) at various doses (1/100, 0.5/100, 0.5/50, or 0.25/50)
Number of subjects: 1835
Study 31913228 — intervention group
Group type: EXPERIMENTAL
Intervention: TX-001HR
Number of subjects: 1835
Study 31913228 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1835
Study 30829213 — intervention group
Group type: EXPERIMENTAL
Intervention: Mukalbion poly herbal chewable tablets
Number of subjects: 70
Study 30829213 — intervention group
Group type: COMPARATOR
Intervention: Marketed brand (Poly herbal)
Number of subjects: 70